Patients who developed a coronary aneurysm after coronary interventions and patients with a history of coronary artery bypass graft surgery, bicuspid aortic valve, a known diagnosis of autoimmune disease, current infection, or on medications that increase ANA titers. This evidence concerns the gene BTG3 and coronary aneurysm.